About Molecular Vision
Molecular Vision is a company based in London (United Kingdom) founded in 2001 was acquired by Abingdon Health in March 2012.. The company has 1 employees as of June 30, 2022. Molecular Vision operates in a competitive market with competitors including Pr3vent, Toku Eyes, TearLab, Gobiquity and Quantel Medical, among others.
- Headquarter London, United Kingdom
- Employees 1 as on 30 Jun, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Molecular Vision Limited
- Date of Incorporation 24 Sep, 2001
- Jurisdiction YORK, ENGLAND
-
Annual Revenue
-
Net Profit
$-230.5 K (USD)0as on Dec 31, 2020
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
1
as on Jun 30, 2022
-
Acquired by
Abingdon Health
(Mar 01, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Molecular Vision
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Molecular Vision
Molecular Vision has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abingdon Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of immunoassays for diagnostic purposes
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Molecular Vision
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Molecular Vision
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Molecular Vision Comparisons
Competitors of Molecular Vision
Molecular Vision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pr3vent, Toku Eyes, TearLab, Gobiquity and Quantel Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based platform for newborn ophthalmic condition screening is offered.
|
|
| domain | founded_year | HQ Location |
AI-powered retinal images are analyzed for early disease detection.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic tests for detecting hyperosmolarity
|
|
| domain | founded_year | HQ Location |
Smartphone apps are developed to detect and track eye diseases.
|
|
| domain | founded_year | HQ Location |
Ultrasound and laser devices for ophthalmology are manufactured and marketed.
|
|
| domain | founded_year | HQ Location |
Provider of diagnostic, screening, and lens finishing equipment for eye care
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Molecular Vision
When was Molecular Vision founded?
Molecular Vision was founded in 2001.
Where is Molecular Vision located?
Molecular Vision is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
How many employees does Molecular Vision have?
As of Jun 30, 2022, the latest employee count at Molecular Vision is 1.
What does Molecular Vision do?
Molecular Vision was founded in 2001 in London, United Kingdom, as a spin-out from Imperial College London. An optical detection platform using organic light emitting diodes and organic photodetectors was developed for quantitative analysis in portable, disposable formats. Patent-protected technology supports low-cost medical diagnostics for point-of-care markets, enabling tests for multiple disease markers on single devices. Acquisition by Abingdon Health occurred in January 2015.
Who are the top competitors of Molecular Vision?
Who are Molecular Vision's investors?
Molecular Vision has 1 investor. Key investors include Abingdon Health.